{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_52610"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_52610","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"STUDYING THE USABILITY OF FRONT OF PACK (FOP) WARNING LABELS IN OVER-THE-COUNTER MEDICATIONS AS A TOOL TO REDUCE ADVERSE DRUG REACTIONS IN OLDER ADULTS.","abstract":"Thesis (Ph.D.)--Michigan State University. Packaging - Doctor of Philosophy, 2025","abstract_html":"Thesis (Ph.D.)--Michigan State University. Packaging - Doctor of Philosophy, 2025","abstract_has_math":false,"creators":["Venkatesan, Krishnaa"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Bix, Laura","Becker, Mark W","Auras, Rafael","Lee, Euihark"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025","date_published":"2025","updated_at":"2026-11-18T18:59:09Z","subjects":["Packaging"],"languages":["eng"],"rights":["Attribution-NonCommercial-NoDerivatives 4.0 International"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52610","local:Venkatesan_grad.msu_0128D_21573"],"render_values":[{"text":"etd:52610","href":null,"code":true},{"text":"local:Venkatesan_grad.msu_0128D_21573","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/0vp8-px21","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/0vp8-px21","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_52610","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Bix, Laura","Becker, Mark W","Auras, Rafael","Lee, Euihark"]},{"key":"dc:creator","label":"Author","values":["Venkatesan, Krishnaa"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2025"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["text","Electronic dissertations"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Packaging"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["Attribution-NonCommercial-NoDerivatives 4.0 International"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52610","local:Venkatesan_grad.msu_0128D_21573","https://doi.org/doi:10.25335/0vp8-px21"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (Ph.D.)--Michigan State University. Packaging - Doctor of Philosophy, 2025","Over-the-counter (OTC) medications are a popular medication option for patients who want a cheap, safe, and effective alternative to prescription drugs. However, they do carry some risks and can cause adverse drug events (ADEs) under specific circumstances. This risk is compounded by the poor design of the warning labels and the lack of expert intervention during the purchase and use of these OTCs. The prevalence of polypharmacy, the changing physiology, and the difference in the pharmacokinetics in the geriatric population make them especially susceptible to ADEs.Effectively communicating with the patients about the contraindications and the interaction risks of the OTCs can help reduce the risk and ultimately the occurrence of ADEs. The drug facts label (DFL) is the primary source of information that patients must rely on to get this information for OTCs, as the process of purchasing and using OTC medication is largely self-guided and lacks any professional intervention. However, the poor design of the DFL, including low readability, high clutter, and small font size, makes the DFL a poor warning communication tool. Front-of-Pack (FOP) labeling is a technique that brings abridged critical information to the principal display panel (PDP) to increase the exposure of this information to the user and hence make it more conspicuous and usable. Though there is no official standard for an FOP label in the United States, FOP labels are becoming increasingly popular in the food packaging industry. Despite their popularity in the food industry, FOP labels are not used with OTC medicines. FOP labels could help increase exposure to critical information and help reduce information overload, both of which are currently issues with the DFL. Preliminary research on FOP labels on OTC packages has been promising, and FOP labels and highlighting have been reported to increase the conspicuousness of critical information and demonstrate improvements in early-stage information processing during habitual processing and goal-directed processing. Therefore, we proposed a novel FOP labeling strategy with OTC drugs to improve the usability of the warning labels. An FOP panel that contained the drug-drug and drug-diagnosis warnings necessary to make an accurate assessment of their appropriateness was created and placed in the PDP. The critical information in the PDP and DFL was also highlighted to garner attention. Before this was tested, we created a study to objectively measure the amount of information needed by the participants to accurately assess 10 commonly available single active-ingredient OTCs. The participants were presented with varying levels of information: only brand name(fictitious), only active ingredient, only purpose (of the med), the entire PDP, and the entire DFL, and tasked with assessing their appropriateness for self-use. The results suggested that providing more visual information to the participants did not make them more accurate, i.e., the DFL trial participant responses (estimated accuracy = 53.2 ± 2.88%) were not more accurate than brand name trials (estimated accuracy = 52.5 ± 2.88%). The next two studies focused on the impact of FOP and Highlighting (HL) on the participants’ ability to accurately assess the appropriateness of 12 commercially available OTCs. In both experiments, the participants were presented with a standard OTC label or an FOP label and tasked with assessing their appropriateness for self-use; however, in one of the experiments, gray-scale labels with fictitious brand names were used, and in the other, life-like labels with existing OTC brands were used. Eye-tracking was employed to study how often the participants looked at the FOP, and the results suggested that the probability of the participant attending to the information on the FOP when it was present was low (~50%). The presence of an FOP had no measurable effect on the participants’ response, response time, and response confidence in either study. In conclusion, the results suggest that FOP is not effective in improving participant accuracy of their assessment of OTCs’ appropriateness for self-use.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","1 online resource (366 p.) : ill."]},{"key":"dc:title","label":"Title","values":["STUDYING THE USABILITY OF FRONT OF PACK (FOP) WARNING LABELS IN OVER-THE-COUNTER MEDICATIONS AS A TOOL TO REDUCE ADVERSE DRUG REACTIONS IN OLDER ADULTS."]}]}],"canonical_facts":{"dc:contributor":["Bix, Laura","Becker, Mark W","Auras, Rafael","Lee, Euihark"],"dc:creator":["Venkatesan, Krishnaa"],"dc:date":["2025"],"dc:description":["Thesis (Ph.D.)--Michigan State University. Packaging - Doctor of Philosophy, 2025","Over-the-counter (OTC) medications are a popular medication option for patients who want a cheap, safe, and effective alternative to prescription drugs. However, they do carry some risks and can cause adverse drug events (ADEs) under specific circumstances. This risk is compounded by the poor design of the warning labels and the lack of expert intervention during the purchase and use of these OTCs. The prevalence of polypharmacy, the changing physiology, and the difference in the pharmacokinetics in the geriatric population make them especially susceptible to ADEs.Effectively communicating with the patients about the contraindications and the interaction risks of the OTCs can help reduce the risk and ultimately the occurrence of ADEs. The drug facts label (DFL) is the primary source of information that patients must rely on to get this information for OTCs, as the process of purchasing and using OTC medication is largely self-guided and lacks any professional intervention. However, the poor design of the DFL, including low readability, high clutter, and small font size, makes the DFL a poor warning communication tool. Front-of-Pack (FOP) labeling is a technique that brings abridged critical information to the principal display panel (PDP) to increase the exposure of this information to the user and hence make it more conspicuous and usable. Though there is no official standard for an FOP label in the United States, FOP labels are becoming increasingly popular in the food packaging industry. Despite their popularity in the food industry, FOP labels are not used with OTC medicines. FOP labels could help increase exposure to critical information and help reduce information overload, both of which are currently issues with the DFL. Preliminary research on FOP labels on OTC packages has been promising, and FOP labels and highlighting have been reported to increase the conspicuousness of critical information and demonstrate improvements in early-stage information processing during habitual processing and goal-directed processing. Therefore, we proposed a novel FOP labeling strategy with OTC drugs to improve the usability of the warning labels. An FOP panel that contained the drug-drug and drug-diagnosis warnings necessary to make an accurate assessment of their appropriateness was created and placed in the PDP. The critical information in the PDP and DFL was also highlighted to garner attention. Before this was tested, we created a study to objectively measure the amount of information needed by the participants to accurately assess 10 commonly available single active-ingredient OTCs. The participants were presented with varying levels of information: only brand name(fictitious), only active ingredient, only purpose (of the med), the entire PDP, and the entire DFL, and tasked with assessing their appropriateness for self-use. The results suggested that providing more visual information to the participants did not make them more accurate, i.e., the DFL trial participant responses (estimated accuracy = 53.2 ± 2.88%) were not more accurate than brand name trials (estimated accuracy = 52.5 ± 2.88%). The next two studies focused on the impact of FOP and Highlighting (HL) on the participants’ ability to accurately assess the appropriateness of 12 commercially available OTCs. In both experiments, the participants were presented with a standard OTC label or an FOP label and tasked with assessing their appropriateness for self-use; however, in one of the experiments, gray-scale labels with fictitious brand names were used, and in the other, life-like labels with existing OTC brands were used. Eye-tracking was employed to study how often the participants looked at the FOP, and the results suggested that the probability of the participant attending to the information on the FOP when it was present was low (~50%). The presence of an FOP had no measurable effect on the participants’ response, response time, and response confidence in either study. In conclusion, the results suggest that FOP is not effective in improving participant accuracy of their assessment of OTCs’ appropriateness for self-use.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."],"dc:format":["application/pdf","1 online resource (366 p.) : ill."],"dc:identifier":["etd:52610","local:Venkatesan_grad.msu_0128D_21573","https://doi.org/doi:10.25335/0vp8-px21"],"dc:language":["eng"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["Attribution-NonCommercial-NoDerivatives 4.0 International"],"dc:subject":["Packaging"],"dc:title":["STUDYING THE USABILITY OF FRONT OF PACK (FOP) WARNING LABELS IN OVER-THE-COUNTER MEDICATIONS AS A TOOL TO REDUCE ADVERSE DRUG REACTIONS IN OLDER ADULTS."],"dc:type":["text","Electronic dissertations"]},"updated_at":"2026-11-18T18:59:09Z"}